Sally Miller, Shashank Kulkarni, Alex Ciesielski, Spyros P. Nikas, Ken Mackie, Alexandros Makriyannis, & Alex Straiker. (2018). Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. MDPI AG.
Chicago Style (17th ed.) CitationSally Miller, Shashank Kulkarni, Alex Ciesielski, Spyros P. Nikas, Ken Mackie, Alexandros Makriyannis, and Alex Straiker. Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. MDPI AG, 2018.
MLA (9th ed.) CitationSally Miller, et al. Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. MDPI AG, 2018.
Warning: These citations may not always be 100% accurate.